Interferon‐γ Response by Peripheral Blood Mononuclear Cells to Hepatitis C Virus Core Antigen Is Reduced in Patients with Liver Fibrosis
Author(s) -
Mark Watson,
Aleksandra Jaksic,
Patricia Price,
Wendy Cheng,
Marian McInerney,
Martyn A. French,
Scott Fisher,
Silvia Lee,
James Flexman
Publication year - 2003
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/379252
Subject(s) - peripheral blood mononuclear cell , fibrosis , medicine , immunology , antigen , hepatitis c virus , hepatitis c , interferon , hepatitis , cytomegalovirus , liver disease , interferon gamma , virology , virus , pathology , viral disease , cytokine , herpesviridae , biology , biochemistry , in vitro
Liver fibrosis was correlated with immunological parameters. Peripheral blood mononuclear cells (PBMCs) from patients with low fibrosis scores had more [corrected] interferon (IFN)-gamma-producing cells than did patients with higher fibrosis scores, when stimulated with hepatitis C virus (HCV) core antigen. Irrespective of liver fibrosis score, cells from all cytomegalovirus (CMV)-seropositive patients had similar IFN-gamma responses, when stimulated by CMV antigen, so patients with fibrosis did not have a broad-spectrum immunodeficiency. IFN-gamma response by PBMCs to HCV core antigen may provide a useful marker of the severity of liver disease in patients with hepatitis C.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom